OpGen Inc (OPGN) is Initiated by Rodman & Renshaw to Buy, Price Target at $2.50

OpGen Inc (OPGN) was Initiated by Rodman & Renshaw to “Buy” and the brokerage firm has set the Price Target at $2.50. Rodman & Renshaw advised their investors in a research report released on Jun 29, 2016.

OpGen Inc closed down -0.02 points or -1.41% at $1.4 with 11,430 shares getting traded on Monday. Post opening the session at $1.3093, the shares hit an intraday low of $1.24 and an intraday high of $1.4001 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

In a different news, on May 23, 2016, Kevin Krenitsky (President) purchased 43,716 shares at $0.00 per share price. According to the SEC, on May 23, 2016, Evan/ Fa Jones (CEO) purchased 874,317 shares at $0.00 per share price. On May 23, 2016, Timothy J.r. Harris (director) purchased 43,716 shares at $0.00 per share price, according to the Form-4 filing with the securities and exchange commission.

OpGen Inc. is a United States-based Company that provides optical mapping solutions for life sciences. The Company offers optical mapping services for analysis of microbial yeast and fungal genomic architecture. It offers its optical mapping technology for life science clinical and food microbiology life science epidemiology pharmacology microbial forensics manufacturing quality control and applied research applications. Its map analysis software module includes with the Argus Whole Genome Mapping System which provides analysis for microbial samples and genomes up to 100Mb.

OpGen Inc

Leave a Reply

OpGen Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on OpGen Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.